库尔库米诺类药物和表面活性剂配制的黄素对抗化疗性结肠直肠癌的作用
Chunping Wan1,2, Qinge Ma2,3, Samantha Anderson2
1Central Laboratory, No. 1, Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Kunming 650021, P. R. China.
The American journal of Chinese medicine
|July 19, 2023
概括
一种新的黄素配方 (CuminUP60) 显示出对抗耐化疗结直肠癌 (CRC) 的承诺. 这种增强的生物可用性黄素有效地减少了SW-480癌细胞的增殖和调节免疫反应.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 大肠直肠癌 (CRC) 是癌症死亡的一个重要原因.
- 慢性肠道炎症是CRC发展的已知危险因素.
- 黄的主要成分是黄,它具有抗癌性质,但生物可用性差.
研究的目的:
- 评估一种新型表面活性剂配制的黄素 (CuminUP60) 对抗耐化疗结直肠癌的化学预防效果.
- 为了研究CuminUP60对抗化疗结直肠癌细胞系的影响.
- 评估CuminUP60对与肠道恶性瘤相关的免疫反应的影响.
主要方法:
- 使用了一种新型表面活性剂配制的黄素 (CuminUP60) 水溶液.
- 对抗化疗耐药性SW-480结肠直肠癌细胞系的抗增殖作用进行评估.
- 分析了亡诱导,细胞循环停止 (G2/M阶段),环林B1表达和Th17细胞分化.
主要成果:
- CuminUP60在SW-480细胞上表现出显著的剂量和时间依赖的抗增殖作用.
- 该配方通过上调环林B1.1,诱导了早期的亡和G2/M细胞周期停止.
- CuminUP60 抑制了 Th17 细胞分化,这表明它具有免疫调节作用.
结论:
- 表面活性剂配制的黄素 (CuminUP60) 对抗耐化疗结直肠癌细胞表现出强烈的活性.
- 该配方增强了黄素的生物可用性,并通过亡和细胞循环停止表现出抗癌作用.
- CuminUP60可能为治疗耐化疗结直肠癌和调节免疫反应提供一种潜在的治疗策略.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Drugs for Treatment of Ulcerative Colitis in IBD
175
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
175
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K


